Dasatinib
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dasatinib and local guidelines before prescribing.
Tyrosine kinase inhibitor
Mechanism
BCR-ABL and SRC tyrosine kinase inhibitor.
Uses
Chronic myeloid leukaemia, Ph-positive ALL.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Myelosuppression, pleural effusion, pulmonary hypertension, bleeding, QT prolongation.
Interactions
PPIs and H2 blockers reduce absorption; CYP3A4 interactions.
Contraindications and cautions
Hypersensitivity
Monitoring
FBC, ECG, CXR if dyspnoea
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in hepatic impairment
Overdose and reversal
Supportive
Special advice
Monitor for pleural effusion; BCR-ABL PCR.
More from the textbook: uses, cautions and other points
- Imatinib , dasatinib, nilotinib, ponatinib (BCR-ABL tyrosine kinase) | CML , Philadelphia-positive ALL | Fluid retention, muscle cramps, rash, marrow suppression; dasatinib - pleural effusions; nilotinib - QT, vascular events; ponatinib - arterial clots; CYP3A4 interactions
Haematology: Anatomy Physiology and Pharmacology - Imatinib / dasatinib / nilotinib / bosutinib / asciminib | CML (and Ph-positive ALL); BCR–ABL PCR monitoring; dasatinib - pleural effusions; nilotinib - vascular events, QT.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - Drugs (methotrexate, amiodarone, dasatinib).
Respiratory: Lung Cancer - Drugs and toxins - appetite suppressants (fenfluramine), methamphetamine , dasatinib, interferon.
Respiratory: Pulmonary Vascular Disease - Dasatinib - pleural effusions , pulmonary hypertension.
Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia - BCR-ABL | Imatinib, dasatinib, nilotinib | Chronic myeloid leukaemia (Philadelphia chromosome t(9;22))
Cell Biology: Cell cycle, signalling, cell death and stem cells
Where it is discussed in the book
- Respiratory: Lung Cancer (1 mention)
- Respiratory: Pulmonary Vascular Disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (2 mentions)
- Integrated respiratory chapter (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)